(redirected from photodynamic therapy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
See: treatment
References in periodicals archive ?
For photodynamic therapy, a photosensitizing agent is applied to the cervix and accumulates in the premalignant cells, he explained.
Photodynamic therapy as adjunct to non-surgical periodontal treatment in patients on periodontal maintenance: a randomized controlled clinical trial.
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus.
For example, one patient's carotid artery ruptured during photodynamic therapy for a tumor embedded in the artery.
There are a range of treatments available for non-melanoma skin cancers and photodynamic therapy is among the newer ones.
For photodynamic therapy, the photo-sensitizing agent porfimer sodium was injected and the esophagus was exposed to light at a wavelength of 630 nm and an energy density of 150-250 J/cm.
Miravant Medical Technologies specializes in PhotoPoint(R) photodynamic therapy (PDT), developing photoreactive (light-activated) drugs to selectively target diseased cells and blood vessels.
In addition, photodynamic therapy has been used investigationally to treat various conditions such as retinal problems associated with the eyes and precancerous conditions of the esophagus or bladder.
is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with a primary focus on dermatology.
This new photodynamic therapy system for treating AKs is the first to deliver ALA topically; the solution is applied directly to the lesion, followed by exposure to the BLU-U.
President of the American Society of Photodynamic Therapy (ASPDT), and lead author of the recent article 'Use of PDT in Dermatology: Results of a Consensus Conference', (Nestor et al, 2006), stated "The consensus conference concluded that ALA PDT using blue light and/or IPL can play an important role in the treatment of patients with Type C (severe) photo-damaged skin, helping treat not only actinic keratoses, but also the appearance and 'quality' of the skin.
In exchange for an undisclosed fee, Corixa will provide QLT with the exclusive right to use certain proprietary immunotherapeutic compounds for certain diseases, which QLT intends to evaluate in combination with photodynamic therapy in the treatment of disease.